Table: begin end state 1 11 cytoplasmic 12 32 transmembrane 33 51 non-cytoplasmic 52 72 transmembrane 73 81 cytoplasmic 82 101 transmembrane 102 109 non-cytoplasmic 110 133 transmembrane 134 144 cytoplasmic 145 166 transmembrane 167 179 non-cytoplasmic 180 200 transmembrane 201 233 cytoplasmic 234 256 transmembrane 257 269 non-cytoplasmic 270 291 transmembrane 292 298 cytoplasmic 299 318 transmembrane 319 323 non-cytoplasmic 324 346 transmembrane 347 357 cytoplasmic 358 378 transmembrane 379 383 non-cytoplasmic 384 403 transmembrane 404 410 cytoplasmic
Input: >WP_091369124.1 NCBI__GCF_900105165.1:WP_091369124.1 MDQKPAFTEPKYRVILFFVTALFMLWGIAITLGDVLNRHFQNVLHISKSHSGLVQLSIFG AYAVMGIPAGLFMKRFGYKKGILLGLFLYAFGAFLFVPAADAVSFDFFRIALFILACGLA TLETVAHPFVAALGDQRTSDQRINFSQAFNGLGGVIGPTLGGYFILKGQQIHSNDLIAVK YLYVIIGSVIVLIGVLFLFLKVPHLTHAHNEVIDYENAEGNKKIEKKLIHQKHYVFAVVA QFFNVAAQGGTWAYFINYGHEMVHLSDERAAYFFSLSMIMLMIGRFTGTFLMRYIAPYRL LSIFAAANIVMCLIVAQGAGWLSFIALLFINFFFSIMFPTIFSLGLKNLGGKTQQGSSFI VMGVIGGGLFPPLMGLIANHDIAAAYYLPIICYIVIFLFGYCYPRLAKPN
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server